Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIS: Ibodutant in Irritable Bowel Syndrome
NCT00761007Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ibodutant in irritable bowel syndrome (IBS), sponsored by Menarini Group. Started Jul 2008; status: completed.
02
Drugs
ibodutant
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00761007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761007.